SEI Investments’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.83M Buy
169,631
+91,744
+118% +$2.3M ﹤0.01% 1633
2026
Q1
$1.95M Buy
77,887
+6,937
+10% +$195K ﹤0.01% 2023
2025
Q4
$2.23M Buy
70,950
+1,913
+3% +$63.4K ﹤0.01% 1796
2025
Q3
$2.46M Buy
69,037
+22,140
+47% +$1.01M ﹤0.01% 1617
2025
Q2
$2.7M Buy
46,897
+2,452
+6% +$139K ﹤0.01% 1532
2025
Q1
$2.59M Sell
44,445
-50,870
-53% -$3.47M ﹤0.01% 1530
2024
Q4
$7.67M Buy
95,315
+62,359
+189% +$5.33M 0.01% 1096
2024
Q3
$2.64M Sell
32,956
-3,180
-9% -$226K ﹤0.01% 1558
2024
Q2
$2.21M Buy
36,136
+13,359
+59% +$795K ﹤0.01% 1590
2024
Q1
$1.13M Buy
22,777
+6,011
+36% +$286K ﹤0.01% 1836
2023
Q4
$703K Sell
16,766
-175,626
-91% -$5.98M ﹤0.01% 1985
2023
Q3
$6.31M Buy
192,392
+60,895
+46% +$2.08M 0.01% 1056
2023
Q2
$4.65M Buy
131,497
+101,422
+337% +$3.35M 0.01% 1230
2023
Q1
$854K Buy
+30,075
New +$1.06M ﹤0.01% 1931
2022
Q4
Sell
-13,924
Closed -$577K 2649
2022
Q3
$577K Buy
13,924
+2,391
+21% +$95.4K ﹤0.01% 2017
2022
Q2
$377K Buy
+11,533
New +$420K ﹤0.01% 2224

Other funds holding PRCT

SEI Investments's PRCT Position: Q2 2026 in Review

SEI Investments increased its Procept Biorobotics (PRCT) stake by 118% in Q2 2026, buying an estimated $2.3M and bringing the position to 169,631 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #1633.

SEI Investments first reported a position in PRCT in Q2 2022 and has held it in 16 quarters since. The position peaked at $7.67M in Q4 2024. 254 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • SEI Investments held 169,631 shares of Procept Biorobotics worth $3.83M as of Q2 2026.
  • SEI Investments bought 91,744 Procept Biorobotics shares in Q2 2026, an estimated $2.3M.
  • Procept Biorobotics made up ﹤0.01% of SEI Investments's portfolio in Q2 2026, its #1633 holding.
  • SEI Investments first reported a position in Procept Biorobotics in Q2 2022 and has held it in 16 quarters since.
  • SEI Investments's Procept Biorobotics position peaked at $7.67M in Q4 2024.
  • 254 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on SEI Investments's 13F filing for Q2 2026, filed 14 Aug 2026.